$189 Million is the total value of Endurant Capital Management LP's 48 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 67.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $15,915,000 | +6.4% | 119,071 | +51.6% | 8.41% | +26.4% |
| CI | New | CIGNA CORP NEW | $13,474,000 | – | 70,944 | +100.0% | 7.12% | – |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $12,851,000 | +147.1% | 123,905 | +213.2% | 6.79% | +193.5% |
| CELG | Buy | CELGENE CORP | $10,806,000 | +22.7% | 168,609 | +71.3% | 5.71% | +45.8% |
| CVS | Buy | CVS HEALTH CORP | $9,673,000 | +34.4% | 147,629 | +61.5% | 5.11% | +59.7% |
| MDT | Buy | MEDTRONIC PLC | $8,444,000 | +31.8% | 92,827 | +42.5% | 4.46% | +56.6% |
| SHPG | Sell | SHIRE PLCsponsored adr | $8,023,000 | -50.9% | 46,100 | -48.9% | 4.24% | -41.7% |
| WMGI | Sell | WRIGHT MED GROUP N V | $7,679,000 | -13.9% | 282,108 | -8.2% | 4.06% | +2.3% |
| DVA | Buy | DAVITA INC | $7,242,000 | +44.2% | 140,729 | +100.8% | 3.83% | +71.4% |
| RCM | Buy | R1 RCM INC | $7,103,000 | +49.6% | 893,421 | +91.1% | 3.75% | +77.7% |
| IIN | Buy | INTRICON CORP | $6,542,000 | +227.9% | 247,980 | +598.7% | 3.46% | +289.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $5,895,000 | +23.0% | 461,234 | +56.2% | 3.12% | +46.2% |
| MDRX | Buy | ALLSCRIPTS HEALTHCARE SOLUTN | $5,702,000 | +423.1% | 591,533 | +673.3% | 3.01% | +521.4% |
| HOLX | Buy | HOLOGIC INC | $5,582,000 | +46.4% | 135,805 | +46.0% | 2.95% | +73.9% |
| ICLR | Buy | ICON PLC | $5,315,000 | +114.7% | 41,132 | +155.5% | 2.81% | +155.1% |
| EHC | New | ENCOMPASS HEALTH CORP | $5,261,000 | – | 85,272 | +100.0% | 2.78% | – |
| XRAY | New | DENTSPLY SIRONA INC | $4,407,000 | – | 118,424 | +100.0% | 2.33% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $4,168,000 | +126.3% | 16,732 | +141.7% | 2.20% | +169.0% |
| SNY | Sell | SANOFIsponsored adr | $3,534,000 | -40.6% | 81,401 | -38.9% | 1.87% | -29.5% |
| PODD | New | INSULET CORP | $3,230,000 | – | 40,727 | +100.0% | 1.71% | – |
| BHC | Sell | BAUSCH HEALTH COS INC | $3,027,000 | -28.3% | 163,908 | -0.3% | 1.60% | -14.8% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $2,816,000 | +3.4% | 318,185 | +31.4% | 1.49% | +22.8% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $2,565,000 | -47.0% | 49,337 | -36.7% | 1.36% | -37.0% |
| Buy | FLUIDIGM CORP DELnote 2.750% 2/0 | $2,517,000 | +486.7% | 2,750,000 | +450.0% | 1.33% | +596.3% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $2,359,000 | +72.7% | 21,615 | +155.6% | 1.25% | +105.1% |
| NVRO | Buy | NEVRO CORP | $2,138,000 | +55.2% | 54,977 | +127.5% | 1.13% | +84.3% |
| MYL | Sell | MYLAN N V | $2,113,000 | -46.4% | 77,135 | -28.4% | 1.12% | -36.4% |
| FLDM | Sell | FLUIDIGM CORP DEL | $2,040,000 | -51.6% | 236,648 | -57.9% | 1.08% | -42.5% |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $1,798,000 | – | 232,048 | +100.0% | 0.95% | – |
| PETS | New | PETMED EXPRESS INC | $1,559,000 | – | 67,010 | +100.0% | 0.82% | – |
| ARAY | New | ACCURAY INC | $1,552,000 | – | 455,018 | +100.0% | 0.82% | – |
| ARRY | Sell | ARRAY BIOPHARMA INC | $1,458,000 | -14.9% | 102,345 | -9.2% | 0.77% | +1.2% |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $1,252,000 | – | 18,018 | +100.0% | 0.66% | – |
| SYK | Sell | STRYKER CORP | $1,147,000 | -75.9% | 7,319 | -72.7% | 0.61% | -71.4% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $1,139,000 | – | 73,884 | +100.0% | 0.60% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $1,080,000 | -60.2% | 30,560 | -56.6% | 0.57% | -52.7% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $926,000 | -55.5% | 232,727 | -23.0% | 0.49% | -47.1% |
| JNJ | Buy | JOHNSON & JOHNSON | $850,000 | +149.3% | 6,588 | +166.8% | 0.45% | +195.4% |
| LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $848,000 | +28.3% | 39,139 | +62.5% | 0.45% | +52.4% |
| AXGN | Buy | AXOGEN INC | $816,000 | -23.8% | 39,961 | +37.4% | 0.43% | -9.5% |
| ANAB | New | ANAPTYSBIO INC | $812,000 | – | 12,734 | +100.0% | 0.43% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $620,000 | – | 8,340 | +100.0% | 0.33% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $590,000 | +79.9% | 209,195 | +119.8% | 0.31% | +113.7% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $558,000 | -34.8% | 58,240 | -17.7% | 0.30% | -22.6% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $553,000 | -42.8% | 66,639 | -4.8% | 0.29% | -32.1% |
| MCK | Buy | MCKESSON CORP | $549,000 | +46.8% | 4,966 | +76.0% | 0.29% | +74.7% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $409,000 | -67.4% | 53,466 | -25.7% | 0.22% | -61.3% |
| KRYS | New | KRYSTAL BIOTECH INC | $260,000 | – | 12,500 | +100.0% | 0.14% | – |
| HSGX | Exit | HISTOGENICS CORP | $0 | – | -39,978 | -100.0% | -0.01% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -3,581 | -100.0% | -0.12% | – |
| ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -18,340 | -100.0% | -0.18% | – |
| AKTX | Exit | AKARI THERAPEUTICS PLCsponsored adr | $0 | – | -163,609 | -100.0% | -0.19% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -26,534 | -100.0% | -0.20% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -3,703 | -100.0% | -0.20% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -219,114 | -100.0% | -0.21% | – |
| CLSD | Exit | CLEARSIDE BIOMEDICAL INC | $0 | – | -94,259 | -100.0% | -0.26% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -64,065 | -100.0% | -0.27% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -3,674 | -100.0% | -0.28% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -3,806 | -100.0% | -0.30% | – |
| OFIX | Exit | ORTHOFIX MED INC | $0 | – | -11,478 | -100.0% | -0.30% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -32,371 | -100.0% | -0.30% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -2,576 | -100.0% | -0.30% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -75,971 | -100.0% | -0.32% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -8,305 | -100.0% | -0.35% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -10,315 | -100.0% | -0.35% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -39,456 | -100.0% | -0.38% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -54,523 | -100.0% | -0.41% | – |
| MD | Exit | MEDNAX INC | $0 | – | -20,959 | -100.0% | -0.44% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -168,840 | -100.0% | -0.45% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -25,081 | -100.0% | -0.51% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -17,286 | -100.0% | -0.54% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -46,513 | -100.0% | -0.58% | – |
| Exit | ENDOLOGIX INCnote 2.250%12/1 | $0 | – | -1,541,000 | -100.0% | -0.66% | – | |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -19,865 | -100.0% | -0.83% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -19,673 | -100.0% | -0.94% | – |
| DHR | Exit | DANAHER CORP DEL | $0 | – | -19,949 | -100.0% | -0.96% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -204,333 | -100.0% | -1.48% | – |
| PFE | Exit | PFIZER INC | $0 | – | -92,390 | -100.0% | -1.81% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -17,008 | -100.0% | -2.07% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -23,017 | -100.0% | -2.08% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -68,190 | -100.0% | -2.34% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -80,093 | -100.0% | -2.53% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -78,718 | -100.0% | -2.57% | – |
| TVTY | Exit | TIVITY HEALTH INC | $0 | – | -310,596 | -100.0% | -4.44% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -82,814 | -100.0% | -7.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.